Popular on PrZen
- The 4th Annual Newark Summit for Economic Development, Placemaking & Innovation Returns on December 8th - 661
- OncoBeta Introduces Rhenium-SCT for Non-Melanoma Skin Cancer at Theageneio Cancer Hospital of Thessaloniki - 645
- Alan Hamilton of Shiver Hamilton Campbell Inducted as a Fellow of the American College of Trial Lawyers - 640
- Club Wyndham Research Identifies the "Holiday Rewind Effect": 93% of Parents Recreate Their Own Childhood Holidays for Their Kids - 604
- "The Tree of Cinema" Installation Brought Film History and Its Audiences Together at TIFF 2026 - 567
- New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA? - 560
- The Fifth Annual "Bamboo Lantern Festival" to Illuminate Tokyo Mizumachi and Sumida River Walk® - 552
- Romanian Software Company ASSIST Software Ranks Second Nationally Among Large Enterprises in Its Category - 548
- 450 Million Revenue Run Rate, Global Telecom Reach and a New Digital Growth Opportunity Take Center Stage: IQSTEL, Inc. (N A S D A Q: IQST) - 546
- Attorney Jason M. Sullivan Quoted in The Telegraph on Trump's $10 Billion BBC Lawsuit - 518
Similar on PrZen
- Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position
- Commercial Sales for U.S.-Made, Preservative-Free Ketamine Amid Long-Runnin Shortage Following FDA Approval by NRx Pharmaceuticals, Inc
- Contracting Resources Group Receives 2026 HIRE Vets Platinum Medallion Award
- TCA VG: 2025 Funding Climbs to $9M across 43 Companies; Cumulative Returns Reach 5.3 MOIC & 22% IRR
- Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape
- Contracting Resources Group Named a 2027 Elev8 GovCon Honoree by OrangeSlices
- New Six-Figure Media Agreement Builds Powerful Momentum, Expanding Government Contracts, FBI Access and Growing AI Recognition: Cyabra (NAS DAQ: CYAB)
- Qscription Technologies Welcomes Joanna Krause, MD, MRMD to Its Clinical Advisory Board
- Romanian Software Company ASSIST Software Ranks Second Nationally Among Large Enterprises in Its Category
- New Omega-3 Fish Oil Under NIH Investigation: What Makes It Different From EPA and DHA?
synseer Nominated for Best Startup in 2026 Prix Galien USA Awards Following Record Breaking Applicant Pool
PrZen/33620954
Nomination recognizes synseer's mission to transform the ear into a continuous health-intelligence platform helping people understand, manage and extend their healthspan.
BOCA RATON, Fla. - PrZen -- synseer Technologies, LLC, a health-intelligence pioneer developing an ear-based operating system for continuous biosensing and personalized health insights, is proud to announce that it has been nominated in the Best Startup category of the 2026 Prix Galien USA Awards.
Presented by The Galien Foundation, the Prix Galien USA Awards recognize scientific and technological innovation with the potential to meaningfully advance human health. The 2026 Best Startup category attracted a record-breaking field of more than 250 applicants, and synseer has been placed among a select group of nominees identified for their potential contribution to the future of healthcare. The 2026 Prix Galien USA Awards Ceremony will be held on October 29, 2026, at the American Museum of Natural History in New York City.
"As someone who has launched multiple companies dedicated to making biometric data more accessible, understandable, and useful in people's everyday lives," said John A. Martino II, synseer Founder and CEO, "this recognition is especially meaningful because the Prix Galien celebrates innovation directed towards improving human health. Galien's mission is closely aligned with why we are building synseer. We want to provide people with personalized health insights that help guide future decisions, not just provide a snapshot of the past."
Martino continues, "our broader vision is the creation of an ear-based Health Intelligence Operating System capable of observing changes across multiple dimensions of health and wellness over time — including cardiovascular, hearing, activity, sleep, temperature, movement and other physiological signals — while establishing an increasingly individualized understanding of what is normal for each user. With this personal baseline, we can help people recognize meaningful changes that may warrant greater attention."
The 2026 Prix Galien USA Awards mark two decades of recognizing innovations and organizations helping shape the future of healthcare. synseer is honored to join this year's distinguished group of nominees and innovators working to advance human health.
About synseer
synseer is an emerging health-intelligence venture building an ear-based health operating system that turns continuous physiological sensing into personalized, actionable insight. synseer's ear-based platform will power a portfolio of wearables—including HealthBuds™ and HealthAids™—designed to capture how multiple dimensions of health and wellness interact over time, delivering a richer, more longitudinal view of personal health. synseer's mission is to advance wearable technology beyond passive measurement toward a deeper, more individualized understanding of human health, empowering people to take a more informed role in managing their healthspan. https://synseer.ai
About the Prix Galien USA Awards: www.galienfoundation.org/prix-galien-usa.
Presented by The Galien Foundation, the Prix Galien USA Awards recognize scientific and technological innovation with the potential to meaningfully advance human health. The 2026 Best Startup category attracted a record-breaking field of more than 250 applicants, and synseer has been placed among a select group of nominees identified for their potential contribution to the future of healthcare. The 2026 Prix Galien USA Awards Ceremony will be held on October 29, 2026, at the American Museum of Natural History in New York City.
"As someone who has launched multiple companies dedicated to making biometric data more accessible, understandable, and useful in people's everyday lives," said John A. Martino II, synseer Founder and CEO, "this recognition is especially meaningful because the Prix Galien celebrates innovation directed towards improving human health. Galien's mission is closely aligned with why we are building synseer. We want to provide people with personalized health insights that help guide future decisions, not just provide a snapshot of the past."
Martino continues, "our broader vision is the creation of an ear-based Health Intelligence Operating System capable of observing changes across multiple dimensions of health and wellness over time — including cardiovascular, hearing, activity, sleep, temperature, movement and other physiological signals — while establishing an increasingly individualized understanding of what is normal for each user. With this personal baseline, we can help people recognize meaningful changes that may warrant greater attention."
The 2026 Prix Galien USA Awards mark two decades of recognizing innovations and organizations helping shape the future of healthcare. synseer is honored to join this year's distinguished group of nominees and innovators working to advance human health.
About synseer
synseer is an emerging health-intelligence venture building an ear-based health operating system that turns continuous physiological sensing into personalized, actionable insight. synseer's ear-based platform will power a portfolio of wearables—including HealthBuds™ and HealthAids™—designed to capture how multiple dimensions of health and wellness interact over time, delivering a richer, more longitudinal view of personal health. synseer's mission is to advance wearable technology beyond passive measurement toward a deeper, more individualized understanding of human health, empowering people to take a more informed role in managing their healthspan. https://synseer.ai
About the Prix Galien USA Awards: www.galienfoundation.org/prix-galien-usa.
Contact
synseer Technologies, LLC
Dorothy.wetzel@synseer.ai, 917-860-8124, www.synseer.ai
***@synseer.ai
synseer Technologies, LLC
Dorothy.wetzel@synseer.ai, 917-860-8124, www.synseer.ai
***@synseer.ai
Source: synseer
0 Comments
Latest on PrZen
- UK Financial Ltd Launches MayaSwap On MAYA CHAIN To Facilitate UKFLMS-For-Gold Swaps, Officially Transforming UKFLMS From Meme Into A Real-World Asset
- Entrepreneur Nouho M Kanneh Talks Family, Faith and a $37 Million Portfolio in New Interview
- Emerald Williams Selected to Super Lawyers Rising Stars 2022-2026
- Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position
- Orlando Real Estate Broker Bent Danholm Wins 2026 Goody Business Book Award for The Architecture of Demand
- Commercial Sales for U.S.-Made, Preservative-Free Ketamine Amid Long-Runnin Shortage Following FDA Approval by NRx Pharmaceuticals, Inc
- The King Returns: Satirical December 2026 Rematch Sees Challenger Delayed by a Christmas Light Installation
- LCH2 Awarded Additional $1 Million to Advance Lewis County Clean Energy Campus
- Security Planning Tips For Your Holiday Event From Access Patrol Services
- Contracting Resources Group Receives 2026 HIRE Vets Platinum Medallion Award
- Business News & Info Goes Inside Paragon FX Group's Hunt for Original Film Props
- Kitchen Table Economics: An Invitation to Think Differently
- Win a $5,000 VIP Family Experience at the 100th Thanksgiving Day Parade in New York City
- CB Stuffer Announces Private Sale to Secure Future of Brand Growth
- The Fifth Annual "Bamboo Lantern Festival" to Illuminate Tokyo Mizumachi and Sumida River Walk®
- Iglesia.com Positioned in Multimillion-Dollar Domain Market with $10 Million Asking Price
- Searching for the Next LBE Creator: CalArts Launches First-Ever D.R.E.A.M.S. Pitch Competition
- TCA VG: 2025 Funding Climbs to $9M across 43 Companies; Cumulative Returns Reach 5.3 MOIC & 22% IRR
- Integris Composites Joins International Sea Power Conference Aboard HMS Prince of Wales
- Commercial Sales Launch Following FDA Approval; National Sales Force Now in Action as January Shipments and Major Market Opportunity Take Shape


